List of Tables
Table 1. Global Long-acting Glucocorticoid Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Long-acting Glucocorticoid Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Long-acting Glucocorticoid Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Long-acting Glucocorticoid Injection Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Long-acting Glucocorticoid Injection Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Long-acting Glucocorticoid Injection Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Long-acting Glucocorticoid Injection Sales by Region (2020-2025) & (K Units)
Table 8. Global Long-acting Glucocorticoid Injection Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Long-acting Glucocorticoid Injection Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Long-acting Glucocorticoid Injection Sales Share by Manufacturers (2020-2025)
Table 12. Global Long-acting Glucocorticoid Injection Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Long-acting Glucocorticoid Injection Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Long-acting Glucocorticoid Injection by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Glucocorticoid Injection as of 2024)
Table 16. Global Long-acting Glucocorticoid Injection Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Long-acting Glucocorticoid Injection Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Long-acting Glucocorticoid Injection Manufacturing Base and Headquarters
Table 19. Global Long-acting Glucocorticoid Injection Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Long-acting Glucocorticoid Injection Sales by Type (2020-2025) & (K Units)
Table 23. Global Long-acting Glucocorticoid Injection Sales by Type (2026-2031) & (K Units)
Table 24. Global Long-acting Glucocorticoid Injection Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Long-acting Glucocorticoid Injection Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Long-acting Glucocorticoid Injection ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Long-acting Glucocorticoid Injection Sales by Application (2020-2025) & (K Units)
Table 29. Global Long-acting Glucocorticoid Injection Sales by Application (2026-2031) & (K Units)
Table 30. Long-acting Glucocorticoid Injection High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Long-acting Glucocorticoid Injection Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Long-acting Glucocorticoid Injection Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Long-acting Glucocorticoid Injection ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Long-acting Glucocorticoid Injection Growth Accelerators and Market Barriers
Table 37. North America Long-acting Glucocorticoid Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Long-acting Glucocorticoid Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Long-acting Glucocorticoid Injection Growth Accelerators and Market Barriers
Table 40. Europe Long-acting Glucocorticoid Injection Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Long-acting Glucocorticoid Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Long-acting Glucocorticoid Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Long-acting Glucocorticoid Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Long-acting Glucocorticoid Injection Growth Accelerators and Market Barriers
Table 45. Southeast Asia Long-acting Glucocorticoid Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Long-acting Glucocorticoid Injection Investment Opportunities and Key Challenges
Table 47. Central and South America Long-acting Glucocorticoid Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Long-acting Glucocorticoid Injection Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Long-acting Glucocorticoid Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Eurocrit Labs Corporation Information
Table 51. Eurocrit Labs Description and Major Businesses
Table 52. Eurocrit Labs Product Models, Descriptions and Specifications
Table 53. Eurocrit Labs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Eurocrit Labs Sales Value Proportion by Product in 2024
Table 55. Eurocrit Labs Sales Value Proportion by Application in 2024
Table 56. Eurocrit Labs Sales Value Proportion by Geographic Area in 2024
Table 57. Eurocrit Labs Long-acting Glucocorticoid Injection SWOT Analysis
Table 58. Eurocrit Labs Recent Developments
Table 59. Pyxus Pharmaceutical Corporation Information
Table 60. Pyxus Pharmaceutical Description and Major Businesses
Table 61. Pyxus Pharmaceutical Product Models, Descriptions and Specifications
Table 62. Pyxus Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Pyxus Pharmaceutical Sales Value Proportion by Product in 2024
Table 64. Pyxus Pharmaceutical Sales Value Proportion by Application in 2024
Table 65. Pyxus Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 66. Pyxus Pharmaceutical Long-acting Glucocorticoid Injection SWOT Analysis
Table 67. Pyxus Pharmaceutical Recent Developments
Table 68. SiNi Pharma Corporation Information
Table 69. SiNi Pharma Description and Major Businesses
Table 70. SiNi Pharma Product Models, Descriptions and Specifications
Table 71. SiNi Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. SiNi Pharma Sales Value Proportion by Product in 2024
Table 73. SiNi Pharma Sales Value Proportion by Application in 2024
Table 74. SiNi Pharma Sales Value Proportion by Geographic Area in 2024
Table 75. SiNi Pharma Long-acting Glucocorticoid Injection SWOT Analysis
Table 76. SiNi Pharma Recent Developments
Table 77. Zydus Cadila Corporation Information
Table 78. Zydus Cadila Description and Major Businesses
Table 79. Zydus Cadila Product Models, Descriptions and Specifications
Table 80. Zydus Cadila Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Zydus Cadila Sales Value Proportion by Product in 2024
Table 82. Zydus Cadila Sales Value Proportion by Application in 2024
Table 83. Zydus Cadila Sales Value Proportion by Geographic Area in 2024
Table 84. Zydus Cadila Long-acting Glucocorticoid Injection SWOT Analysis
Table 85. Zydus Cadila Recent Developments
Table 86. Weefsel Pharma Corporation Information
Table 87. Weefsel Pharma Description and Major Businesses
Table 88. Weefsel Pharma Product Models, Descriptions and Specifications
Table 89. Weefsel Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Weefsel Pharma Sales Value Proportion by Product in 2024
Table 91. Weefsel Pharma Sales Value Proportion by Application in 2024
Table 92. Weefsel Pharma Sales Value Proportion by Geographic Area in 2024
Table 93. Weefsel Pharma Long-acting Glucocorticoid Injection SWOT Analysis
Table 94. Weefsel Pharma Recent Developments
Table 95. Taj Pharmaceuticals Limited Corporation Information
Table 96. Taj Pharmaceuticals Limited Description and Major Businesses
Table 97. Taj Pharmaceuticals Limited Product Models, Descriptions and Specifications
Table 98. Taj Pharmaceuticals Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Taj Pharmaceuticals Limited Recent Developments
Table 100. Wellona Pharma Corporation Information
Table 101. Wellona Pharma Description and Major Businesses
Table 102. Wellona Pharma Product Models, Descriptions and Specifications
Table 103. Wellona Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Wellona Pharma Recent Developments
Table 105. Caspian Tamin Pharmaceutical Company Corporation Information
Table 106. Caspian Tamin Pharmaceutical Company Description and Major Businesses
Table 107. Caspian Tamin Pharmaceutical Company Product Models, Descriptions and Specifications
Table 108. Caspian Tamin Pharmaceutical Company Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Caspian Tamin Pharmaceutical Company Recent Developments
Table 110. AdvaCare Pharma Corporation Information
Table 111. AdvaCare Pharma Description and Major Businesses
Table 112. AdvaCare Pharma Product Models, Descriptions and Specifications
Table 113. AdvaCare Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. AdvaCare Pharma Recent Developments
Table 115. Key Raw Materials Distribution
Table 116. Raw Materials Key Suppliers
Table 117. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 118. Milestones in Production Technology Evolution
Table 119. Distributors List
Table 120. Market Trends and Market Evolution
Table 121. Market Drivers and Opportunities
Table 122. Market Challenges, Risks, and Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Long-acting Glucocorticoid Injection Product Picture
Figure 2. Global Long-acting Glucocorticoid Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Dexamethasone Hormone Injection Product Picture
Figure 4. Betamethasone Hormone Injection Product Picture
Figure 5. Global Long-acting Glucocorticoid Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Rheumatoid Arthritis
Figure 7. Allergic Diseases
Figure 8. Bronchial Asthma
Figure 9. Autoimmune Disease
Figure 10. Skin Diseases
Figure 11. Others
Figure 12. Long-acting Glucocorticoid Injection Report Years Considered
Figure 13. Global Long-acting Glucocorticoid Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Long-acting Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 15. Global Long-acting Glucocorticoid Injection Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Long-acting Glucocorticoid Injection Revenue Market Share by Region (2020-2031)
Figure 17. Global Long-acting Glucocorticoid Injection Sales (2020-2031) & (K Units)
Figure 18. Global Long-acting Glucocorticoid Injection Sales (CAGR) by Region (2020-2031) (K Units)
Figure 19. Global Long-acting Glucocorticoid Injection Sales Market Share by Region (2020-2031)
Figure 20. Top 5 and Top 10 Manufacturers Long-acting Glucocorticoid Injection Sales Volume Market Share in 2024
Figure 21. Global Long-acting Glucocorticoid Injection Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. Dexamethasone Hormone Injection Revenue Market Share by Manufacturer in 2024
Figure 24. Betamethasone Hormone Injection Revenue Market Share by Manufacturer in 2024
Figure 25. Global Long-acting Glucocorticoid Injection Sales Market Share by Type (2020-2031)
Figure 26. Global Long-acting Glucocorticoid Injection Revenue Market Share by Type (2020-2031)
Figure 27. Global Long-acting Glucocorticoid Injection Sales Market Share by Application (2020-2031)
Figure 28. Global Long-acting Glucocorticoid Injection Revenue Market Share by Application (2020-2031)
Figure 29. North America Long-acting Glucocorticoid Injection Sales YoY (2020-2031) & (K Units)
Figure 30. North America Long-acting Glucocorticoid Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 31. North America Top 5 Manufacturers Long-acting Glucocorticoid Injection Sales Revenue (US$ Million) in 2024
Figure 32. North America Long-acting Glucocorticoid Injection Sales Volume (K Units) by Type (2020- 2031)
Figure 33. North America Long-acting Glucocorticoid Injection Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 34. North America Long-acting Glucocorticoid Injection Sales Volume (K Units) by Application (2020-2031)
Figure 35. North America Long-acting Glucocorticoid Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 36. US Long-acting Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 37. Canada Long-acting Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 38. Mexico Long-acting Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 39. Europe Long-acting Glucocorticoid Injection Sales YoY (2020-2031) & (K Units)
Figure 40. Europe Long-acting Glucocorticoid Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Europe Top 5 Manufacturers Long-acting Glucocorticoid Injection Sales Revenue (US$ Million) in 2024
Figure 42. Europe Long-acting Glucocorticoid Injection Sales Volume (K Units) by Type (2020-2031)
Figure 43. Europe Long-acting Glucocorticoid Injection Sales Revenue (US$ Million) by Type (2020-2031)
Figure 44. Europe Long-acting Glucocorticoid Injection Sales Volume (K Units) by Application (2020-2031)
Figure 45. Europe Long-acting Glucocorticoid Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 46. Germany Long-acting Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 47. France Long-acting Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 48. U.K. Long-acting Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 49. Italy Long-acting Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 50. Russia Long-acting Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Long-acting Glucocorticoid Injection Sales YoY (2020-2031) & (K Units)
Figure 52. Asia-Pacific Long-acting Glucocorticoid Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Top 8 Manufacturers Long-acting Glucocorticoid Injection Sales Revenue (US$ Million) in 2024
Figure 54. Asia-Pacific Long-acting Glucocorticoid Injection Sales Volume (K Units) by Type (2020- 2031)
Figure 55. Asia-Pacific Long-acting Glucocorticoid Injection Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 56. Asia-Pacific Long-acting Glucocorticoid Injection Sales Volume (K Units) by Application (2020-2031)
Figure 57. Asia-Pacific Long-acting Glucocorticoid Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 58. Indonesia Long-acting Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 59. Japan Long-acting Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 60. South Korea Long-acting Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 61. China Taiwan Long-acting Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 62. India Long-acting Glucocorticoid Injection Revenue (2020-2031) & (US$ Million)
Figure 63. Central and South America Long-acting Glucocorticoid Injection Sales YoY (2020-2031) & (K Units)
Figure 64. Central and South America Long-acting Glucocorticoid Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Central and South America Top 5 Manufacturers Long-acting Glucocorticoid Injection Sales Revenue (US$ Million) in 2024
Figure 66. Central and South America Long-acting Glucocorticoid Injection Sales Volume (K Units) by Type (2021-2031)
Figure 67. Central and South America Long-acting Glucocorticoid Injection Sales Revenue (US$ Million) by Type (2020-2031)
Figure 68. Central and South America Long-acting Glucocorticoid Injection Sales Volume (K Units) by Application (2020-2031)
Figure 69. Central and South America Long-acting Glucocorticoid Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 70. Brazil Long-acting Glucocorticoid Injection Revenue (2020-2025) & (US$ Million)
Figure 71. Argentina Long-acting Glucocorticoid Injection Revenue (2020-2025) & (US$ Million)
Figure 72. Middle East, and Africa Long-acting Glucocorticoid Injection Sales YoY (2020-2031) & (K Units)
Figure 73. Middle East and Africa Long-acting Glucocorticoid Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 74. Middle East and Africa Top 5 Manufacturers Long-acting Glucocorticoid Injection Sales Revenue (US$ Million) in 2024
Figure 75. Middle East and Africa Long-acting Glucocorticoid Injection Sales Volume (K Units) by Type (2021-2031)
Figure 76. South America Long-acting Glucocorticoid Injection Sales Revenue (US$ Million) by Type (2020-2031)
Figure 77. Middle East and Africa Long-acting Glucocorticoid Injection Sales Volume (K Units) by Application (2020-2031)
Figure 78. Middle East and Africa Long-acting Glucocorticoid Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 79. GCC Countries Long-acting Glucocorticoid Injection Revenue (2020-2025) & (US$ Million)
Figure 80. Turkey Long-acting Glucocorticoid Injection Revenue (2020-2025) & (US$ Million)
Figure 81. Egypt Long-acting Glucocorticoid Injection Revenue (2020-2025) & (US$ Million)
Figure 82. South Africa Long-acting Glucocorticoid Injection Revenue (2020-2025) & (US$ Million)
Figure 83. Long-acting Glucocorticoid Injection Industry Chain Mapping
Figure 84. Regional Long-acting Glucocorticoid Injection Manufacturing Base Distribution (%)
Figure 85. Global Long-acting Glucocorticoid Injection Production Market Share by Region (2020-2031)
Figure 86. Long-acting Glucocorticoid Injection Production Process
Figure 87. Regional Long-acting Glucocorticoid Injection Production Cost Structure
Figure 88. Channels of Distribution (Direct Vs Distribution)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
